327 related articles for article (PubMed ID: 9365173)
1. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
Yamamoto S; Konishi I; Mandai M; Kuroda H; Komatsu T; Nanbu K; Sakahara H; Mori T
Br J Cancer; 1997; 76(9):1221-7. PubMed ID: 9365173
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
4. CA 125 and vascular endothelial growth factor in the differential diagnosis of epithelial ovarian tumors.
Candido Dos Reis F; Moreira de Andrade J; Bighetti S
Gynecol Obstet Invest; 2002; 54(3):132-6. PubMed ID: 12571433
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic protein expression in advanced epithelial ovarian cancer.
Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Reich R; Kopolovic J; Berner A; Nesland JM; Kristensen GB; Tropé CG; Bryne M; Risberg B; van de Putte G; Goldberg I
Clin Exp Metastasis; 2002; 19(2):135-44. PubMed ID: 11964077
[TBL] [Abstract][Full Text] [Related]
7. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.
Nakanishi Y; Kodama J; Yoshinouchi M; Tokumo K; Kamimura S; Okuda H; Kudo T
Int J Gynecol Pathol; 1997 Jul; 16(3):256-62. PubMed ID: 9421092
[TBL] [Abstract][Full Text] [Related]
8. Secretion of vascular endothelial growth factor in ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Cannon MJ; Pecorelli S; Parham GP
Eur J Gynaecol Oncol; 1999; 20(3):177-81. PubMed ID: 10410879
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers.
Fujimoto J; Sakaguchi H; Aoki I; Khatun S; Tamaya T
Br J Cancer; 2001 Aug; 85(3):313-6. PubMed ID: 11487257
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma.
Nakayama K; Kanzaki A; Hata K; Katabuchi H; Okamura H; Miyazaki K; Fukumoto M; Takebayashi Y
Cancer Lett; 2002 Feb; 176(2):215-23. PubMed ID: 11804750
[TBL] [Abstract][Full Text] [Related]
13. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor and social support in patients with ovarian carcinoma.
Lutgendorf SK; Johnsen EL; Cooper B; Anderson B; Sorosky JI; Buller RE; Sood AK
Cancer; 2002 Aug; 95(4):808-15. PubMed ID: 12209725
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
Cooper BC; Ritchie JM; Broghammer CL; Coffin J; Sorosky JI; Buller RE; Hendrix MJ; Sood AK
Clin Cancer Res; 2002 Oct; 8(10):3193-7. PubMed ID: 12374688
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression in early stage ovarian carcinoma.
Paley PJ; Staskus KA; Gebhard K; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
Cancer; 1997 Jul; 80(1):98-106. PubMed ID: 9210714
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy.
Hazelton D; Nicosia RF; Nicosia SV
Clin Cancer Res; 1999 Apr; 5(4):823-9. PubMed ID: 10213218
[TBL] [Abstract][Full Text] [Related]
18. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
[TBL] [Abstract][Full Text] [Related]
19. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma.
Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T
Cancer; 1998 Dec; 83(12):2528-33. PubMed ID: 9874459
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
